References
- Smith D. W. Recognizable Patterns of Human Malformation, 2nd ed. Saunders, Philadelphia 1976; 346–347
- Schardein J. L. CRS Drugs as Teratogens. CRS Press, Cleveland 1976; 113–115
- Hanson J. W. Risks of the offspring of women treated with hydantoin anticonvulsant and emphasis on the fetal hydan-toin syndrome. J. Pediatr. 1976; 89: 662–668
- Allen R. W., Ogden B., Bentley F. L., Jung A. L. Fetal hydantoin syndrome, neuroblastoma and hemorrhagic disease in a neonate. J. Am. Med. Assoc 1980; 244: 1464–1465
- Hanson J. W., Smith D. W. The fetal hydantoin syndrome. J. Pediatr. 1975; 87: 285–290
- Meadow S. R., Speidel B. D. Epilepsy, anticonvulsants and congenital malformations. Drugs 1974; 8: 354–365
- Hill R. M., Verniaud W. M., Horning M. G., McCulley L. B., Morgan N. F. Infants exposed in utero to antiepileptic drugs. A prospective study. Am. J. Pis. Child. 1974; 127: 645–653